REYATAZ is a member of the class of drugs known as protease inhibitors. Adults and children between the ages of 6 and 18 who are HIV-positive are treated with REYATAZ in combination with other anti-HIV medications (HIV).

Kitmeds © 2021. All Rights Reserved.